Particle.news
Download on the App Store
6 ARTICLES
·
last wk.

CDC Vaccine Panel Reconvenes to Address Key Immunization Updates After Delay

The Advisory Committee on Immunization Practices is reviewing RSV and COVID-19 vaccine guidelines and responding to a measles outbreak following a two-month postponement.

A general view of the Centers for Disease Control and Prevention headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell/File Photo
FILE - A sign stands at an entrance to the main campus of the Center for Disease Control and Prevention (CDC) in Atlanta, Georgia, Friday, Feb. 14, 2025. (AP Photo/Jeff Amy, File)
A view shows MMR vaccine at the City of Lubbock Health Department in Lubbock, Texas, U.S. February 27, 2025. REUTERS/Annie Rice/File Photo
U.S. Health and Human Services Secretary Robert F. Kennedy, Jr speaks during a Make Indiana Healthy Again initiative event in Indianapolis, Tuesday, April 15, 2025. (AP Photo/Michael Conroy)

Overview

  • The CDC's Advisory Committee on Immunization Practices (ACIP) has reconvened after a nearly two-month delay to update vaccine recommendations for the upcoming respiratory season.
  • Key agenda items include lowering the recommended age for RSV vaccination to 50 and revising COVID-19 vaccine guidelines for the 2025-2026 season.
  • The panel is also addressing a measles outbreak that has infected over 700 people, primarily among unvaccinated populations in Texas and New Mexico.
  • The delay in ACIP's meeting coincided with the appointment of vaccine skeptic Robert F. Kennedy Jr. as head of HHS, raising concerns about political influence on public health policy.
  • Votes on certain resolutions, including the Vaccines for Children Program, remain postponed, potentially impacting access to free flu vaccines for children this fall.